{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:16:53Z","timestamp":1773947813313,"version":"3.50.1"},"reference-count":171,"publisher":"Bentham Science Publishers Ltd.","issue":"16","funder":[{"DOI":"10.13039\/501100001807","name":"Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["Grants 22\/03901-8 and 20\/08615-8."],"award-info":[{"award-number":["Grants 22\/03901-8 and 20\/08615-8."]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Malaria is a devastating infectious disease that affects large swathes of human\npopulations across the planet\u2019s tropical regions. It is caused by parasites of the genus\nPlasmodium, with Plasmodium falciparum being responsible for the most lethal form of\nthe disease. During the intraerythrocytic stage in the human hosts, malaria parasites multiply\nand degrade hemoglobin (Hb) using a battery of proteases, which include two cysteine\nproteases, falcipains 2 and 3 (FP-2 and FP-3). Due to their role as major hemoglobinases,\nFP-2 and FP-3 have been targeted in studies aiming to discover new antimalarials\nand numerous inhibitors with activity against these enzymes, and parasites in culture\nhave been identified. Nonetheless, cross-inhibition of human cysteine cathepsins remains\na serious hurdle to overcome for these compounds to be used clinically. In this article,\nwe have reviewed key functional and structural properties of FP-2\/3 and described different\ncompound series reported as inhibitors of these proteases during decades of active research\nin the field. Special attention is also paid to the wide range of computer-aided\ndrug design (CADD) techniques successfully applied to discover new active compounds.\nFinally, we provide guidelines that, in our understanding, will help advance the rational\ndiscovery of new FP-2\/3 inhibitors.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867331666230913165219","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T14:17:13Z","timestamp":1694701033000},"page":"2234-2263","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Three Decades of Targeting Falcipains to Develop Antiplasmodial\nAgents: What have we Learned and What can be Done Next?"],"prefix":"10.2174","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-8677","authenticated-orcid":true,"given":"Jorge Enrique Hern\u00e1ndez","family":"Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Multiuser Center for Biomolecular Innovation, IBILCE\/UNESP, S\u00e3o Jos\u00e9 do Rio Preto, SP, Brazil"},{"name":"Department\nof Pharmaceutical Sciences, UZA II, University of Vienna, Vienna, 1090, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emir","family":"Salas-Sarduy","sequence":"additional","affiliation":[{"name":"Instituto de Investigaciones\nBiotecnol\u00f3gicas Dr. Rodolfo Ugalde, Universidad Nacional de San Mart\u00edn, CONICET, San\nMart\u00edn, Buenos Aires, Argentina"},{"name":"Escuela de Bio y Nanotecnolog\u00eda (EByN), Universidad de San Mart\u00edn\n(UNSAM), San Mart\u00edn, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian Hern\u00e1ndez","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Multiuser Center for Biomolecular Innovation, IBILCE\/UNESP, S\u00e3o Jos\u00e9 do Rio Preto, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Alberto","family":"Valiente","sequence":"additional","affiliation":[{"name":"Donnelly Centre for Cellular &amp; Biomolecular Research,\nUniversity of Toronto, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghuvir Krishnaswamy","family":"Arni","sequence":"additional","affiliation":[{"name":"Multiuser Center for Biomolecular Innovation, IBILCE\/UNESP, S\u00e3o Jos\u00e9 do Rio Preto, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Geraldo","family":"Pascutti","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Modelagem e Din\u00e2mica Molecular, Instituto de\nBiof\u00edsica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, RJ, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1389450117666161221122432","volume":"19","author":"Bekono B.D.","year":"2018","unstructured":"Bekono B.D.; Ntie-Kang F.; Owono Owono L.C.; Megnassan E.; Targeting cysteine proteases from Plasmodium falciparum: A general overview, rational drug design and computational approaches for drug discovery. Curr Drug Targets  2018,19(5),501-526","journal-title":"Curr Drug Targets"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2174\/092986711795328328","volume":"18","author":"Teixeira C.","year":"2011","unstructured":"Teixeira C.; Gomes J.R.; Gomes P.; Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria. Curr Med Chem  2011,18(10),1555-1572","journal-title":"Curr Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"140362","DOI":"10.1016\/j.bbapap.2020.140362","volume":"1868","author":"Rosenthal P.J.","year":"2020","unstructured":"Rosenthal P.J.; Falcipain cysteine proteases of malaria parasites: An update. Biochim Biophys Acta Proteins Proteomics  2020,1868(3),140362","journal-title":"Biochim Biophys Acta Proteins Proteomics"},{"key":"ref=4","year":"2022","unstructured":"World malaria report.  Available From:  https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2022 (Accessed on March 27th 2023).2022"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s42003-022-03215-0","volume":"5","author":"Zhu L.","year":"2022","unstructured":"Zhu L.; van der Pluijm R.W.; Kucharski M.; Nayak S.; Tripathi J.; White N.J.; Day N.P.J.; Faiz A.; Phyo A.P.; Amaratunga C.; Lek D.; Ashley E.A.; Nosten F.; Smithuis F.; Ginsburg H.; von Seidlein L.; Lin K.; Imwong M.; Chotivanich K.; Mayxay M.; Dhorda M.; Nguyen H.C.; Nguyen T.N.T.; Miotto O.; Newton P.N.; Jittamala P.; Tripura R.; Pukrittayakamee S.; Peto T.J.; Hien T.T.; Dondorp A.M.; Bozdech Z.; Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response. Commun Biol  2022,5(1),274","journal-title":"Commun Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"Ashley E.A.","year":"2014","unstructured":"Ashley E.A.; Dhorda M.; Fairhurst R.M.; Amaratunga C.; Lim P.; Suon S.; Sreng S.; Anderson J.M.; Mao S.; Sam B.; Sopha C.; Chuor C.M.; Nguon C.; Sovannaroth S.; Pukrittayakamee S.; Jittamala P.; Chotivanich K.; Chutasmit K.; Suchatsoonthorn C.; Runcharoen R.; Hien T.T.; Thuy-Nhien N.T.; Thanh N.V.; Phu N.H.; Htut Y.; Han K.T.; Aye K.H.; Mokuolu O.A.; Olaosebikan R.R.; Folaranmi O.O.; Mayxay M.; Khanthavong M.; Hongvanthong B.; Newton P.N.; Onyamboko M.A.; Fanello C.I.; Tshefu A.K.; Mishra N.; Valecha N.; Phyo A.P.; Nosten F.; Yi P.; Tripura R.; Borrmann S.; Bashraheil M.; Peshu J.; Faiz M.A.; Ghose A.; Hossain M.A.; Samad R.; Rahman M.R.; Hasan M.M.; Islam A.; Miotto O.; Amato R.; MacInnis B.; Stalker J.; Kwiatkowski D.P.; Bozdech Z.; Jeeyapant A.; Cheah P.Y.; Sakulthaew T.; Chalk J.; Intharabut B.; Silamut K.; Lee S.J.; Vihokhern B.; Kunasol C.; Imwong M.; Tarning J.; Taylor W.J.; Yeung S.; Woodrow C.J.; Flegg J.A.; Das D.; Smith J.; Venkatesan M.; Plowe C.V.; Stepniewska K.; Guerin P.J.; Dondorp A.M.; Day N.P.; White N.J.; Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med  2014,371(5),411-423","journal-title":"N Engl J Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","volume":"19","author":"van der Pluijm R.W.","year":"2019","unstructured":"van der Pluijm R.W.; Imwong M.; Chau N.H.; Hoa N.T.; Thuy-Nhien N.T.; Thanh N.V.; Jittamala P.; Hanboonkunupakarn B.; Chutasmit K.; Saelow C.; Runjarern R.; Kaewmok W.; Tripura R.; Peto T.J.; Yok S.; Suon S.; Sreng S.; Mao S.; Oun S.; Yen S.; Amaratunga C.; Lek D.; Huy R.; Dhorda M.; Chotivanich K.; Ashley E.A.; Mukaka M.; Waithira N.; Cheah P.Y.; Maude R.J.; Amato R.; Pearson R.D.; Gon\u00e7alves S.; Jacob C.G.; Hamilton W.L.; Fairhurst R.M.; Tarning J.; Winterberg M.; Kwiatkowski D.P.; Pukrittayakamee S.; Hien T.T.; Day N.P.J.; Miotto O.; White N.J.; Dondorp A.M.; Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: A prospective clinical, pharmacological, and genetic study. Lancet Infect Dis  2019,19(9),952-961","journal-title":"Lancet Infect Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","volume":"16","author":"Laurens M.B.","year":"2020","unstructured":"Laurens M.B.; RTS,S\/AS01 vaccine (Mosquirix\u2122): An overview. Hum Vaccin Immunother  2020,16(3),480-489","journal-title":"Hum Vaccin Immunother"},{"key":"ref=9","year":"2021","unstructured":"World malaria report.  Available From:  https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2021 (Accessed on March 27th 2023).2021"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e1693","DOI":"10.1016\/S2214-109X(22)00477-6","volume":"10","author":"Silal S.P.","year":"2022","unstructured":"Silal S.P.; Seasonal targeting of the RTS,S\/AS01 malaria vaccine: A complementary tool but sustained funding is required. Lancet Glob Health  2022,10(12),e1693-e1694","journal-title":"Lancet Glob Health"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/978-1-4419-8414-2_3","volume":"712","author":"Rosenthal P.J.","year":"2011","unstructured":"Rosenthal P.J.; Falcipains and other cysteine proteases of malaria parasites. Adv Exp Med Biol  2011,712,30-48","journal-title":"Adv Exp Med Biol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijantimicag.2017.04.006","volume":"50","author":"Roy K.K.","year":"2017","unstructured":"Roy K.K.; Targeting the active sites of malarial proteases for antimalarial drug discovery: Approaches, progress and challenges. Int J Antimicrob Agents  2017,50(3),287-302","journal-title":"Int J Antimicrob Agents"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/med.20163","volume":"30","author":"Ettari R.","year":"2010","unstructured":"Ettari R.; Bova F.; Zappal\u00e0 M.; Grasso S.; Micale N.; Falcipain-2 inhibitors. Med Res Rev  2010,30(1),136-167","journal-title":"Med Res Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.2174\/1875533XMTA4nNzUc3","volume":"28","author":"Ettari R.","year":"2021","unstructured":"Ettari R.; Previti S.; Di Chio C.; Zappal\u00e0 M.; Falcipain-2 and falcipain-3 inhibitors as promising antimalarial agents. Curr Med Chem  2021,28(15),3010-3031","journal-title":"Curr Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/156802612799362913","volume":"12","author":"Marco M.","year":"2012","unstructured":"Marco M.; Miguel Coteron J.; Falcipain inhibition as a promising antimalarial target. Curr Top Med Chem  2012,12(5),408-444","journal-title":"Curr Top Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.pt.2004.10.001","volume":"20","author":"Khan S.M.","year":"2004","unstructured":"Khan S.M.; Waters A.P.; Malaria parasite transmission stages: An update. Trends Parasitol  2004,20(12),575-580","journal-title":"Trends Parasitol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000058838","volume":"80","author":"Dimopoulos G.","year":"2002","unstructured":"Dimopoulos G.; Kafatos F.C.; Waters A.P.; Sinden R.E.; Malaria parasites and the anopheles mosquito. Chem Immunol  2002,80,27-49","journal-title":"Chem Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S1471-4922(03)00007-2","volume":"19","author":"Kappe S.H.I.","year":"2003","unstructured":"Kappe S.H.I.; Kaiser K.; Matuschewski K.; The Plasmodium sporozoite journey: A rite of passage. Trends Parasitol  2003,19(3),135-143","journal-title":"Trends Parasitol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nrd4573","volume":"14","author":"Wells T.N.C.","year":"2015","unstructured":"Wells T.N.C.; van Huijsduijnen R.H.; Van Voorhis W.C.; Malaria medicines: A glass half full? Nat Rev Drug Discov  2015,14(6),424-442","journal-title":"Nat Rev Drug Discov"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1172\/JCI113766","volume":"82","author":"Rosenthal P.J.","year":"1988","unstructured":"Rosenthal P.J.; McKerrow J.H.; Aikawa M.; Nagasawa H.; Leech J.H.; A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J Clin Invest  1988,82(5),1560-1566","journal-title":"J Clin Invest"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0166-6851(92)90209-3","volume":"51","author":"Rosenthal P.J.","year":"1992","unstructured":"Rosenthal P.J.; Nelson R.G.; Isolation and characterization of a cysteine proteinase gene of Plasmodium falciparum. Mol Biochem Parasitol  1992,51(1),143-152","journal-title":"Mol Biochem Parasitol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"29000","DOI":"10.1074\/jbc.M004459200","volume":"275","author":"Shenai B.R.","year":"2000","unstructured":"Shenai B.R.; Sijwali P.S.; Singh A.; Rosenthal P.J.; Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J Biol Chem  2000,275(37),29000-29010","journal-title":"J Biol Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/bj3600481","volume":"360","author":"Sijwali P.S.","year":"2001","unstructured":"Sijwali P.S.; Shenai B.R.; Gut J.; Singh A.; Rosenthal P.J.; Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem J  2001,360(2),481-489","journal-title":"Biochem J"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.exppara.2005.10.007","volume":"112","author":"Singh N.","year":"2006","unstructured":"Singh N.; Sijwali P.S.; Pandey K.C.; Rosenthal P.J.; Plasmodium falciparum: Biochemical characterization of the cysteine protease falcipain-2\u2032. Exp Parasitol  2006,112(3),187-192","journal-title":"Exp Parasitol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.1073\/pnas.0402738101","volume":"101","author":"Sijwali P.S.","year":"2004","unstructured":"Sijwali P.S.; Kato K.; Seydel K.B.; Gut J.; Lehman J.; Klemba M.; Goldberg D.E.; Miller L.H.; Rosenthal P.J.; \nPlasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites. Proc Natl Acad Sci USA  2004,101(23),8721-8726","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2958.2004.04108.x","volume":"53","author":"Eksi S.","year":"2004","unstructured":"Eksi S.; Czesny B.; Greenbaum D.C.; Bogyo M.; Williamson K.C.; Targeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth. Mol Microbiol  2004,53(1),243-250","journal-title":"Mol Microbiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molbiopara.2006.06.013","volume":"150","author":"Sijwali P.S.","year":"2006","unstructured":"Sijwali P.S.; Koo J.; Singh N.; Rosenthal P.J.; Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum. Mol Biochem Parasitol  2006,150(1),96-106","journal-title":"Mol Biochem Parasitol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1172\/JCI117140","volume":"93","author":"Gluzman I.Y.","year":"1994","unstructured":"Gluzman I.Y.; Francis S.E.; Oksman A.; Smith C.E.; Duffin K.L.; Goldberg D.E.; Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J Clin Invest  1994,93(4),1602-1608","journal-title":"J Clin Invest"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1073\/pnas.022630099","volume":"99","author":"Banerjee R.","year":"2002","unstructured":"Banerjee R.; Liu J.; Beatty W.; Pelosof L.; Klemba M.; Goldberg D.E.; Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc Natl Acad Sci USA  2002,99(2),990-995","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"32411","DOI":"10.1074\/jbc.274.45.32411","volume":"274","author":"Eggleson K.K.","year":"1999","unstructured":"Eggleson K.K.; Duffin K.L.; Goldberg D.E.; Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum. J Biol Chem  1999,274(45),32411-32417","journal-title":"J Biol Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"43000","DOI":"10.1074\/jbc.M408123200","volume":"279","author":"Klemba M.","year":"2004","unstructured":"Klemba M.; Gluzman I.; Goldberg D.E.; A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation. J Biol Chem  2004,279(41),43000-43007","journal-title":"J Biol Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1006\/expr.1995.1033","volume":"80","author":"Rosenthal P.J.","year":"1995","unstructured":"Rosenthal P.J.; Plasmodium falciparum: Effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Exp Parasitol  1995,80(2),272-281","journal-title":"Exp Parasitol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"54088","DOI":"10.1074\/jbc.M409605200","volume":"279","author":"Omara-Opyene A.L.","year":"2004","unstructured":"Omara-Opyene A.L.; Moura P.A.; Sulsona C.R.; Bonilla J.A.; Yowell C.A.; Fujioka H.; Fidock D.A.; Dame J.B.; Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy. J Biol Chem  2004,279(52),54088-54096","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e5156","DOI":"10.1371\/journal.pone.0005156","volume":"4","author":"Subramanian S.","year":"2009","unstructured":"Subramanian S.; Hardt M.; Choe Y.; Niles R.K.; Johansen E.B.; Legac J.; Gut J.; Kerr I.D.; Craik C.S.; Rosenthal P.J.; Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3. PLoS One  2009,4(4),e5156","journal-title":"PLoS One"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1172\/JCI115456","volume":"88","author":"Rosenthal P.J.","year":"1991","unstructured":"Rosenthal P.J.; Wollish W.S.; Palmer J.T.; Rasnick D.; Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J Clin Invest  1991,88(5),1467-1472","journal-title":"J Clin Invest"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1073\/pnas.0307720101","volume":"101","author":"Sijwali P.S.","year":"2004","unstructured":"Sijwali P.S.; Rosenthal P.J.; Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum. Proc Natl Acad Sci USA  2004,101(13),4384-4389","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1182\/blood-2002-01-0101","volume":"100","author":"Hanspal M.","year":"2002","unstructured":"Hanspal M.; Dua M.; Takakuwa Y.; Chishti A.H.; Mizuno A.; Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood  2002,100(3),1048-1054","journal-title":"Blood"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"12870","DOI":"10.1074\/jbc.M708949200","volume":"283","author":"Drew M.E.","year":"2008","unstructured":"Drew M.E.; Banerjee R.; Uffman E.W.; Gilbertson S.; Rosenthal P.J.; Goldberg D.E.; Plasmodium food vacuole plasmepsins are activated by falcipains. J Biol Chem  2008,283(19),12870-12876","journal-title":"J Biol Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"11503","DOI":"10.1073\/pnas.0600489103","volume":"103","author":"Wang S.X.","year":"2006","unstructured":"Wang S.X.; Pandey K.C.; Somoza J.R.; Sijwali P.S.; Kortemme T.; Brinen L.S.; Fletterick R.J.; Rosenthal P.J.; McKerrow J.H.; Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease. Proc Natl Acad Sci  2006,103(31),11503-11508","journal-title":"Proc Natl Acad Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"25425","DOI":"10.1074\/jbc.M603776200","volume":"281","author":"Hogg T.","year":"2006","unstructured":"Hogg T.; Nagarajan K.; Herzberg S.; Chen L.; Shen X.; Jiang H.; Wecke M.; Blohmke C.; Hilgenfeld R.; Schmidt C.L.; Structural and functional characterization of Falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum. J Biol Chem  2006,281(35),25425-25437","journal-title":"J Biol Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/jm8013663","volume":"52","author":"Kerr I.D.","year":"2009","unstructured":"Kerr I.D.; Lee J.H.; Pandey K.C.; Harrison A.; Sajid M.; Rosenthal P.J.; Brinen L.S.; Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: Implications for substrate specificity. J Med Chem  2009,52(3),852-857","journal-title":"J Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbrc.2021.12.080","volume":"590","author":"Chakraborty S.","year":"2022","unstructured":"Chakraborty S.; Alam B.; Biswas S.; New insights of falcipain 2 structure from Plasmodium falciparum 3D7 strain. Biochem Biophys Res Commun  2022,590,145-151","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","volume":"284","author":"Kerr I.D.","year":"2009","unstructured":"Kerr I.D.; Lee J.H.; Farady C.J.; Marion R.; Rickert M.; Sajid M.; Pandey K.C.; Caffrey C.R.; Legac J.; Hansell E.; McKerrow J.H.; Craik C.S.; Rosenthal P.J.; Brinen L.S.; Vinyl sulfones as antiparasitic agents and a structural basis for drug design. J Biol Chem  2009,284(38),25697-25703","journal-title":"J Biol Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12936-019-3043-0","volume":"18","author":"Machin J.M.","year":"2019","unstructured":"Machin J.M.; Kantsadi A.L.; Vakonakis I.; The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site. Malar J  2019,18(1),388","journal-title":"Malar J"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.str.2007.03.012","volume":"15","author":"Wang S.X.","year":"2007","unstructured":"Wang S.X.; Pandey K.C.; Scharfstein J.; Whisstock J.; Huang R.K.; Jacobelli J.; Fletterick R.J.; Rosenthal P.J.; Abrahamson M.; Brinen L.S.; Rossi A.; Sali A.; McKerrow J.H.; The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family. Structure  2007,15(5),535-543","journal-title":"Structure"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.str.2011.03.025","volume":"19","author":"Hansen G.","year":"2011","unstructured":"Hansen G.; Heitmann A.; Witt T.; Li H.; Jiang H.; Shen X.; Heussler V.T.; Rennenberg A.; Hilgenfeld R.; Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium. Structure  2011,19(7),919-929","journal-title":"Structure"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1074\/jbc.M310536200","volume":"279","author":"Pandey K.C.","year":"2004","unstructured":"Pandey K.C.; Sijwali P.S.; Singh A.; Na B.K.; Rosenthal P.J.; Independent intramolecular mediators of folding, activity, and inhibition for the Plasmodium falciparum cysteine protease falcipain-2. J Biol Chem  2004,279(5),3484-3491","journal-title":"J Biol Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"9138","DOI":"10.1073\/pnas.0502368102","volume":"102","author":"Pandey K.C.","year":"2005","unstructured":"Pandey K.C.; Wang S.X.; Sijwali P.S.; Lau A.L.; McKerrow J.H.; Rosenthal P.J.; The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif. Proc Natl Acad Sci USA  2005,102(26),9138-9143","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.molbiopara.2013.01.002","volume":"187","author":"Cotrin S.S.","year":"2013","unstructured":"Cotrin S.S.; Gouv\u00eaa I.E.; Melo P.M.S.; Bagnaresi P.; Assis D.M.; Ara\u00fajo M.S.; Juliano M.A.; Gazarini M.L.; Rosenthal P.J.; Juliano L.; Carmona A.K.; Substrate specificity studies of the cysteine peptidases falcipain-2 and falcipain-3 from Plasmodium falciparum and demonstration of their kininogenase activity. Mol Biochem Parasitol  2013,187(2),111-116","journal-title":"Mol Biochem Parasitol"},{"key":"ref=50","first-page":"861","volume":"51","author":"Rzychon M.","year":"2004","unstructured":"Rzychon M.; Chmiel D.; Stec-Niemczyk J.; Modes of inhibition of cysteine proteases. Acta Biochim Pol  2004,51(4),861-873","journal-title":"Acta Biochim Pol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1021\/cr010182v","volume":"102","author":"Powers J.C.","year":"2002","unstructured":"Powers J.C.; Asgian J.L.; Ekici \u00d6.D.; James K.E.; Irreversible inhibitors of serine, cysteine, and threonine proteases. Chem Rev  2002,102(12),4639-4750","journal-title":"Chem Rev"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1073\/pnas.90.8.3583","volume":"90","author":"Ring C.S.","year":"1993","unstructured":"Ring C.S.; Sun E.; McKerrow J.H.; Lee G.K.; Rosenthal P.J.; Kuntz I.D.; Cohen F.E.; Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc Natl Acad Sci USA  1993,90(8),3583-3587","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/0968-0896(96)00136-8","volume":"4","author":"Li R.","year":"1996","unstructured":"Li R.; Chen X.; Gong B.; Selzer P.M.; Li Z.; Davidson E.; Kurzban G.; Miller R.E.; Nuzum E.O.; McKerrow J.H.; Fletterick R.J.; Gillmor S.A.; Craik C.S.; Kuntz I.D.; Cohen F.E.; Kenyon G.L.; Structure-based design of parasitic protease inhibitors. Bioorg Med Chem  1996,4(9),1421-1427","journal-title":"Bioorg Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1128\/AAC.40.7.1600","volume":"40","author":"Rosenthal P.J.","year":"1996","unstructured":"Rosenthal P.J.; Olson J.E.; Lee G.K.; Palmer J.T.; Klaus J.L.; Rasnick D.; Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob Agents Chemother  1996,40(7),1600-1603","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI116262","volume":"91","author":"Rosenthal P.J.","year":"1993","unstructured":"Rosenthal P.J.; Lee G.K.; Smith R.E.; Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J Clin Invest  1993,91(3),1052-1056","journal-title":"J Clin Invest"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1182\/blood.V87.10.4448.bloodjournal87104448","volume":"87","author":"Gamboa de Dom\u00ednguez N.D.","year":"1996","unstructured":"Gamboa de Dom\u00ednguez N.D.; Rosenthal P.J.; Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites. Blood  1996,87(10),4448-4454","journal-title":"Blood"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1517\/13543776.2013.743992","volume":"23","author":"Mane U.R.","year":"2013","unstructured":"Mane U.R.; Gupta R.C.; Nadkarni S.S.; Giridhar R.R.; Naik P.P.; Yadav M.R.; Falcipain inhibitors as potential therapeutics for resistant strains of malaria: A patent review. Expert Opin Ther Pat  2013,23(2),165-187","journal-title":"Expert Opin Ther Pat"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"10497","DOI":"10.1021\/acs.jmedchem.9b00683","volume":"62","author":"Cianni L.","year":"2019","unstructured":"Cianni L.; Feldmann C.W.; Gilberg E.; G\u00fctschow M.; Juliano L.; Leit\u00e3o A.; Bajorath J.; Montanari C.A.; Can cysteine protease cross-class inhibitors achieve selectivity? J Med Chem  2019,62(23),10497-10525","journal-title":"J Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.3390\/molecules25174031","volume":"25","author":"Citarella A.","year":"2020","unstructured":"Citarella A.; Micale N.; Peptidyl fluoromethyl ketones and their applications in medicinal chemistry. Molecules  2020,25(17),4031","journal-title":"Molecules"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nchembio707","volume":"1","author":"Kato D.","year":"2005","unstructured":"Kato D.; Boatright K.M.; Berger A.B.; Nazif T.; Blum G.; Ryan C.; Chehade K.A.H.; Salvesen G.S.; Bogyo M.; Activity-based probes that target diverse cysteine protease families. Nat Chem Biol  2005,1(1),33-38","journal-title":"Nat Chem Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/978-1-4419-8414-2_7","volume":"712","author":"Sajid M.","year":"2011","unstructured":"Sajid M.; Robertson S.A.; Brinen L.S.; McKerrow J.H.; Cruzain. Adv Exp Med Biol  2011,712,100-115","journal-title":"Adv Exp Med Biol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2174\/157340711798375859","volume":"7","author":"Dunny E.","year":"2011","unstructured":"Dunny E.; Evans P.; Vinyl sulfone containing parasitic cysteinyl protease inhibitors. Curr Bioact Compd  2011,7(4),218-236","journal-title":"Curr Bioact Compd"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/AAC.47.1.154-160.2003","volume":"47","author":"Shenai B.R.","year":"2003","unstructured":"Shenai B.R.; Lee B.J.; Alvarez-Hernandez A.; Chong P.Y.; Emal C.D.; Neitz R.J.; Roush W.R.; Rosenthal P.J.; Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones. Antimicrob Agents Chemother  2003,47(1),154-160","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"29025","DOI":"10.1021\/acsomega.0c03470","volume":"5","author":"Aratikatla E.K.","year":"2020","unstructured":"Aratikatla E.K.; Kalamuddin M.; Malhotra P.; Mohmmed A.; Bhattacharya A.K.; Enantioselective synthesis of \u03b3-phenyl-\u03b3-amino vinyl phosphonates and sulfones and their application to the synthesis of novel highly potent antimalarials. ACS Omega  2020,5(45),29025-29037","journal-title":"ACS Omega"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/prot.22939","volume":"79","author":"Shokhen M.","year":"2011","unstructured":"Shokhen M.; Khazanov N.; Albeck A.; The mechanism of papain inhibition by peptidyl aldehydes. Proteins  2011,79(3),975-985","journal-title":"Proteins"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"6568","DOI":"10.1021\/bi00417a056","volume":"27","author":"Smith R.A.","year":"1988","unstructured":"Smith R.A.; Copp L.J.; Donnelly S.L.; Spencer R.W.; Krantz A.; Inhibition of cathepsin B by peptidyl aldehydes and ketones: Slow-binding behavior of a trifluoromethyl ketone. Biochemistry  1988,27(17),6568-6573","journal-title":"Biochemistry"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"114570","DOI":"10.1016\/j.ejmech.2022.114570","volume":"240","author":"Ma Y.","year":"2022","unstructured":"Ma Y.; Yang K.S.; Geng Z.Z.; Alugubelli Y.R.; Shaabani N.; Vatansever E.C.; Ma X.R.; Cho C.C.; Khatua K.; Xiao J.; Blankenship L.R.; Yu G.; Sankaran B.; Li P.; Allen R.; Ji H.; Xu S.; Liu W.R.; A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals. Eur J Med Chem  2022,240,114570","journal-title":"Eur J Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1128\/AAC.47.12.3810-3814.2003","volume":"47","author":"Lee B.J.","year":"2003","unstructured":"Lee B.J.; Singh A.; Chiang P.; Kemp S.J.; Goldman E.A.; Weinhouse M.I.; Vlasuk G.P.; Rosenthal P.J.; Antimalarial activities of novel synthetic cysteine protease inhibitors. Antimicrob Agents Chemother  2003,47(12),3810-3814","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1039\/c1md00115a","volume":"2","author":"Ehmke V.","year":"2011","unstructured":"Ehmke V.; Kilchmann F.; Heindl C.; Cui K.; Huang J.; Schirmeister T.; Diederich F.; Peptidomimetic nitriles as selective inhibitors for the malarial cysteine protease falcipain-2. MedChemComm  2011,2(8),800-804","journal-title":"MedChemComm"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.bmcl.2007.12.047","volume":"18","author":"Gauthier J.Y.","year":"2008","unstructured":"Gauthier J.Y.; Chauret N.; Cromlish W.; Desmarais S.; Duong L.T.; Falgueyret J.P.; Kimmel D.B.; Lamontagne S.; L\u00e9ger S.; LeRiche T.; Li C.S.; Mass\u00e9 F.; McKay D.J.; Nicoll-Griffith D.A.; Oballa R.M.; Palmer J.T.; Percival M.D.; Riendeau D.; Robichaud J.; Rodan G.A.; Rodan S.B.; Seto C.; Th\u00e9rien M.; Truong V.L.; Venuti M.C.; Wesolowski G.; Young R.N.; Zamboni R.; Black W.C.; The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg Med Chem Lett  2008,18(3),923-928","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.bmcl.2006.11.044","volume":"17","author":"Oballa R.M.","year":"2007","unstructured":"Oballa R.M.; Truchon J.F.; Bayly C.I.; Chauret N.; Day S.; Crane S.; Berthelette C.; A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds. Bioorg Med Chem Lett  2007,17(4),998-1002","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e1023","DOI":"10.1371\/journal.pntd.0001023","volume":"5","author":"Ang K.K.H.","year":"2011","unstructured":"Ang K.K.H.; Ratnam J.; Gut J.; Legac J.; Hansell E.; Mackey Z.B.; Skrzypczynska K.M.; Debnath A.; Engel J.C.; Rosenthal P.J.; McKerrow J.H.; Arkin M.R.; Renslo A.R.; Mining a cathepsin inhibitor library for new antiparasitic drug leads. PLoS Negl Trop Dis  2011,5(5),e1023","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1021\/jm100556b","volume":"53","author":"Coter\u00f3n J.M.","year":"2010","unstructured":"Coter\u00f3n J.M.; Catterick D.; Castro J.; Chaparro M.J.; D\u00edaz B.; Fern\u00e1ndez E.; Ferrer S.; Gamo F.J.; Gordo M.; Gut J.; de las Heras L.; Legac J.; Marco M.; Miguel J.; Mu\u00f1oz V.; Porras E.; de la Rosa J.C.; Ruiz J.R.; Sandoval E.; Ventosa P.; Rosenthal P.J.; Fiandor J.M.; Falcipain inhibitors: Optimization studies of the 2-pyrimidinecarbonitrile lead series. J Med Chem  2010,53(16),6129-6152","journal-title":"J Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.bmcl.2018.03.069","volume":"28","author":"Nizi E.","year":"2018","unstructured":"Nizi E.; Sferrazza A.; Fabbrini D.; Nardi V.; Andreini M.; Graziani R.; Gennari N.; Bresciani A.; Paonessa G.; Harper S.; Peptidomimetic nitrile inhibitors of malarial protease falcipain-2 with high selectivity against human cathepsins. Bioorg Med Chem Lett  2018,28(9),1540-1544","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.bmc.2015.02.062","volume":"23","author":"Chakka S.K.","year":"2015","unstructured":"Chakka S.K.; Kalamuddin M.; Sundararaman S.; Wei L.; Mundra S.; Mahesh R.; Malhotra P.; Mohmmed A.; Kotra L.P.; Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents. Bioorg Med Chem  2015,23(9),2221-2240","journal-title":"Bioorg Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1002\/prot.25322","volume":"85","author":"Hern\u00e1ndez Gonz\u00e1lez J.E.","year":"2017","unstructured":"Hern\u00e1ndez Gonz\u00e1lez J.E.; Hern\u00e1ndez Alvarez L.; Pascutti P.G.; Valiente P.A.; Predicting binding modes of reversible peptide-based inhibitors of falcipain-2 consistent with structure-activity relationships. Proteins  2017,85(9),1666-1683","journal-title":"Proteins"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1016\/j.bmc.2018.07.015","volume":"26","author":"Royo S.","year":"2018","unstructured":"Royo S.; Schirmeister T.; Kaiser M.; Jung S.; Rodr\u00edguez S.; Bautista J.M.; Gonz\u00e1lez F.V.; Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates. Bioorg Med Chem  2018,26(16),4624-4634","journal-title":"Bioorg Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1021\/np8003529","volume":"72","author":"Linington R.G.","year":"2009","unstructured":"Linington R.G.; Clark B.R.; Trimble E.E.; Almanza A.; Ure\u00f1a L.D.; Kyle D.E.; Gerwick W.H.; Antimalarial peptides from marine cyanobacteria: Isolation and structural elucidation of gallinamide A. J Nat Prod  2009,72(1),14-17","journal-title":"J Nat Prod"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.chembiol.2012.09.020","volume":"19","author":"Stolze S.C.","year":"2012","unstructured":"Stolze S.C.; Deu E.; Kaschani F.; Li N.; Florea B.I.; Richau K.H.; Colby T.; van der Hoorn R.A.L.; Overkleeft H.S.; Bogyo M.; Kaiser M.; The antimalarial natural product symplostatin 4 is a nanomolar inhibitor of the food vacuole falcipains. Chem Biol  2012,19(12),1546-1555","journal-title":"Chem Biol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"10557","DOI":"10.1021\/jm501439w","volume":"57","author":"Conroy T.","year":"2014","unstructured":"Conroy T.; Guo J.T.; Elias N.; Cergol K.M.; Gut J.; Legac J.; Khatoon L.; Liu Y.; McGowan S.; Rosenthal P.J.; Hunt N.H.; Payne R.J.; Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials. J Med Chem  2014,57(24),10557-10563","journal-title":"J Med Chem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1021\/acs.jmedchem.9b00504","volume":"62","author":"Stoye A.","year":"2019","unstructured":"Stoye A.; Juillard A.; Tang A.H.; Legac J.; Gut J.; White K.L.; Charman S.A.; Rosenthal P.J.; Grau G.E.R.; Hunt N.H.; Payne R.J.; Falcipain inhibitors based on the natural product gallinamide a are potent in vitro and in vivo antimalarials. J Med Chem  2019,62(11),5562-5578","journal-title":"J Med Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"113454","DOI":"10.1016\/j.ejmech.2021.113454","volume":"220","author":"Aratikatla E.K.","year":"2021","unstructured":"Aratikatla E.K.; Kalamuddin M.; Rana K.C.; Datta G.; Asad M.; Sundararaman S.; Malhotra P.; Mohmmed A.; Bhattacharya A.K.; Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials. Eur J Med Chem  2021,220,113454","journal-title":"Eur J Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/cmdc.200700070","volume":"2","author":"Schulz F.","year":"2007","unstructured":"Schulz F.; Gelhaus C.; Degel B.; Vicik R.; Heppner S.; Breuning A.; Leippe M.; Gut J.; Rosenthal P.J.; Schirmeister T.; Screening of protease inhibitors as antiplasmodial agents. Part I: Aziridines and epoxides. ChemMedChem  2007,2(8),1214-1224","journal-title":"ChemMedChem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"7438","DOI":"10.1021\/acs.jmedchem.2c00123","volume":"65","author":"Li Petri G.","year":"2022","unstructured":"Li Petri G.; Di Martino S.; De Rosa M.; Peptidomimetics: An overview of recent medicinal chemistry efforts toward the discovery of novel small molecule inhibitors. J Med Chem  2022,65(11),7438-7475","journal-title":"J Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1021\/jm060405f","volume":"49","author":"Micale N.","year":"2006","unstructured":"Micale N.; Kozikowski A.P.; Ettari R.; Grasso S.; Zappal\u00e0 M.; Jeong J.J.; Kumar A.; Hanspal M.; Chishti A.H.; Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents. J Med Chem  2006,49(11),3064-3067","journal-title":"J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1021\/jm701141u","volume":"51","author":"Ettari R.","year":"2008","unstructured":"Ettari R.; Nizi E.; Di Francesco M.E.; Dude M.A.; Pradel G.; Vi\u010d\u00edk R.; Schirmeister T.; Micale N.; Grasso S.; Zappal\u00e0 M.; Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors. J Med Chem  2008,51(4),988-996","journal-title":"J Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/cmdc.200800050","volume":"3","author":"Ettari R.","year":"2008","unstructured":"Ettari R.; Nizi E.; Di Francesco M.E.; Micale N.; Grasso S.; Zappal\u00e0 M.; Vi\u010d\u00edk R.; Schirmeister T.; Nonpeptidic vinyl and allyl phosphonates as falcipain-2 inhibitors. ChemMedChem  2008,3(7),1030-1033","journal-title":"ChemMedChem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1021\/jm900047j","volume":"52","author":"Ettari R.","year":"2009","unstructured":"Ettari R.; Micale N.; Schirmeister T.; Gelhaus C.; Leippe M.; Nizi E.; Di Francesco M.E.; Grasso S.; Zappal\u00e0 M.; Novel peptidomimetics containing a vinyl ester moiety as highly potent and selective falcipain-2 inhibitors. J Med Chem  2009,52(7),2157-2160","journal-title":"J Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201402079","volume":"9","author":"Ettari R.","year":"2014","unstructured":"Ettari R.; Pinto A.; Tamborini L.; Angelo I.C.; Grasso S.; Zappal\u00e0 M.; Capodicasa N.; Yzeiraj L.; Gruber E.; Aminake M.N.; Pradel G.; Schirmeister T.; De Micheli C.; Conti P.; Synthesis and biological evaluation of papain-family cathepsin L-like cysteine protease inhibitors containing a 1,4-benzodiazepine scaffold as antiprotozoal agents. ChemMedChem  2014,9(8)","journal-title":"ChemMedChem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1016\/j.bmcl.2008.05.068","volume":"18","author":"Verissimo E.","year":"2008","unstructured":"Verissimo E.; Berry N.; Gibbons P.; Cristiano M.L.S.; Rosenthal P.J.; Gut J.; Ward S.A.; O\u2019Neill P.M.; Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2\/3 inhibitors. Bioorg Med Chem Lett  2008,18(14),4210-4214","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1021\/jm5004528","volume":"57","author":"Oliveira R.","year":"2014","unstructured":"Oliveira R.; Guedes R.C.; Meireles P.; Albuquerque I.S.; Gon\u00e7alves L.M.; Pires E.; Bronze M.R.; Gut J.; Rosenthal P.J.; Prud\u00eancio M.; Moreira R.; O\u2019Neill P.M.; Lopes F.; Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials. J Med Chem  2014,57(11),4916-4923","journal-title":"J Med Chem"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.bmcl.2014.01.062","volume":"24","author":"Weldon D.J.","year":"2014","unstructured":"Weldon D.J.; Shah F.; Chittiboyina A.G.; Sheri A.; Chada R.R.; Gut J.; Rosenthal P.J.; Shivakumar D.; Sherman W.; Desai P.; Jung J.C.; Avery M.A.; Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of \u03b1-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum. Bioorg Med Chem Lett  2014,24(5),1274-1279","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1080\/07391102.2015.1108231","volume":"34","author":"Musyoka T.M.","year":"2016","unstructured":"Musyoka T.M.; Kanzi A.M.; Lobb K.A.; Tastan Bishop \u00d6.; Analysis of non-peptidic compounds as potential malarial inhibitors against Plasmodial cysteine proteases via integrated virtual screening workflow. J Biomol Struct Dyn  2016,34(10),2084-2101","journal-title":"J Biomol Struct Dyn"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/14756366.2014.920839","volume":"30","author":"Bertoldo J.B.","year":"2015","unstructured":"Bertoldo J.B.; Chiaradia-Delatorre L.D.; Mascarello A.; Leal P.C.; Cordeiro M.N.S.; Nunes R.J.; Sarduy E.S.; Rosenthal P.J.; Terenzi H.; Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum. J Enzyme Inhib Med Chem  2015,30(2),299-307","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"23690","DOI":"10.1038\/srep23690","volume":"6","author":"Musyoka T.M.","year":"2016","unstructured":"Musyoka T.M.; Kanzi A.M.; Lobb K.A.; Tastan Bishop \u00d6.; Structure based docking and molecular dynamic studies of plasmodial cysteine proteases against a South African natural compound and its analogs. Sci Rep  2016,6(1),23690","journal-title":"Sci Rep"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.bmcl.2014.01.074","volume":"24","author":"Wang L.","year":"2014","unstructured":"Wang L.; Zhang S.; Zhu J.; Zhu L.; Liu X.; Shan L.; Huang J.; Zhang W.; Li H.; Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening. Bioorg Med Chem Lett  2014,24(5),1261-1264","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/ci200029y","volume":"51","author":"Shah F.","year":"2011","unstructured":"Shah F.; Mukherjee P.; Gut J.; Legac J.; Rosenthal P.J.; Tekwani B.L.; Avery M.A.; Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library. J Chem Inf Model  2011,51(4),852-864","journal-title":"J Chem Inf Model"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1016\/j.bbagen.2018.09.015","volume":"1862","author":"Hern\u00e1ndez-Gonz\u00e1lez J.E.","year":"2018","unstructured":"Hern\u00e1ndez-Gonz\u00e1lez J.E.; Salas-Sarduy E.; Hern\u00e1ndez Ram\u00edrez L.F.; Pascual M.J.; \u00c1lvarez D.E.; Pab\u00f3n A.; Leite V.B.P.; Pascutti P.G.; Valiente P.A.; Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures. Biochim Biophys Acta, Gen Subj  2018,1862(12),2911-2923","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/molecules14020785","volume":"14","author":"Zhu J.","year":"2009","unstructured":"Zhu J.; Chen T.; Liu J.; Ma R.; Lu W.; Huang J.; Li H.; Li J.; Jiang H.; 2-(3,4-dihydro-4-oxothieno[2,3-d] pyrimidin-2-ylthio) acetamides as a new class of falcipain-2 inhibitors. 3. design, synthesis and biological evaluation. Molecules  2009,14(2),785-797","journal-title":"Molecules"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.3390\/molecules16064527","volume":"16","author":"Liu Y.","year":"2011","unstructured":"Liu Y.; Cui K.; Lu W.; Luo W.; Wang J.; Huang J.; Guo C.; Synthesis and antimalarial activity of novel dihydro-artemisinin derivatives. Molecules  2011,16(6),4527-4538","journal-title":"Molecules"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s12272-012-0902-4","volume":"35","author":"Liu Y.","year":"2012","unstructured":"Liu Y.; Lu W.Q.; Cui K.Q.; Luo W.; Wang J.; Guo C.; Synthesis and biological activities of novel artemisinin derivatives as cysteine protease falcipain-2 inhibitors. Arch Pharm Res  2012,35(9),1525-1531","journal-title":"Arch Pharm Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"115155","DOI":"10.1016\/j.bmc.2019.115155","volume":"28","author":"Rana D.","year":"2020","unstructured":"Rana D.; Kalamuddin M.; Sundriyal S.; Jaiswal V.; Sharma G.; Das Sarma K.; Sijwali P.S.; Mohmmed A.; Malhotra P.; Mahindroo N.; Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity. Bioorg Med Chem  2020,28(1),115155","journal-title":"Bioorg Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/S0968-0896(03)00117-2","volume":"11","author":"Batra S.","year":"2003","unstructured":"Batra S.; Sabnis Y.A.; Rosenthal P.J.; Avery M.A.; Structure-based approach to falcipain-2 inhibitors: Synthesis and biological evaluation of 1,6,7-trisubstituted dihydroisoquinolines and isoquinolines. Bioorg Med Chem  2003,11(10),2293-2299","journal-title":"Bioorg Med Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1700251","DOI":"10.1002\/ardp.201700251","volume":"351","author":"Sharma K.","year":"2018","unstructured":"Sharma K.; Shrivastava A.; Mehra R.N.; Deora G.S.; Alam M.M.; Zaman M.S.; Akhter M.; Synthesis of novel benzimidazole acrylonitriles for inhibition of Plasmodium falciparum growth by dual target inhibition. Arch Pharm  2018,351(1),1700251","journal-title":"Arch Pharm"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.bmc.2015.02.029","volume":"23","author":"Singh A.K.","year":"2015","unstructured":"Singh A.K.; Rajendran V.; Pant A.; Ghosh P.C.; Singh N.; Latha N.; Garg S.; Pandey K.C.; Singh B.K.; Rathi B.; Design, synthesis and biological evaluation of functionalized phthalimides: A new class of antimalarials and inhibitors of falcipain-2, a major hemoglobinase of malaria parasite. Bioorg Med Chem  2015,23(8),1817-1827","journal-title":"Bioorg Med Chem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1021\/jm00193a020","volume":"22","author":"Klayman D.L.","year":"1979","unstructured":"Klayman D.L.; Bartosevich J.F.; Griffin T.S.; Mason C.J.; Scovill J.P.; 2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents. J Med Chem  1979,22(7),855-862","journal-title":"J Med Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1021\/jm030549j","volume":"47","author":"Greenbaum D.C.","year":"2004","unstructured":"Greenbaum D.C.; Mackey Z.; Hansell E.; Doyle P.; Gut J.; Caffrey C.R.; Lehrman J.; Rosenthal P.J.; McKerrow J.H.; Chibale K.; Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. J Med Chem  2004,47(12),3212-3219","journal-title":"J Med Chem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bmc.2006.09.055","volume":"15","author":"Chipeleme A.","year":"2007","unstructured":"Chipeleme A.; Gut J.; Rosenthal P.J.; Chibale K.; Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio)semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum. Bioorg Med Chem  2007,15(1),273-282","journal-title":"Bioorg Med Chem"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1016\/S0960-894X(03)00756-X","volume":"13","author":"Chiyanzu I.","year":"2003","unstructured":"Chiyanzu I.; Hansell E.; Gut J.; Rosenthal P.J.; McKerrow J.H.; Chibale K.; Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain. Bioorg Med Chem Lett  2003,13(20),3527-3530","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/cmdc.201000449","volume":"6","author":"Ehmke V.","year":"2011","unstructured":"Ehmke V.; Heindl C.; Rottmann M.; Freymond C.; Schweizer W.B.; Brun R.; Stich A.; Schirmeister T.; Diederich F.; Potent and selective inhibition of cysteine proteases from Plasmodium falciparum and Trypanosoma brucei. ChemMedChem  2011,6(2),273-278","journal-title":"ChemMedChem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/1389557033488079","volume":"3","author":"Schirmeister T.","year":"2003","unstructured":"Schirmeister T.; Kaeppler U.; Non-peptidic inhibitors of cysteine proteases. Mini Rev Med Chem  2003,3(4),361-373","journal-title":"Mini Rev Med Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1021\/jm0101747","volume":"44","author":"Liu M.","year":"2001","unstructured":"Liu M.; Wilairat P.; Go M.L.; Antimalarial alkoxylated and hydroxylated chalcones (corrected): Structure-activity relationship analysis. J Med Chem  2001,44(25),4443-4452","journal-title":"J Med Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1021\/jm00026a010","volume":"38","author":"Li R.","year":"1995","unstructured":"Li R.; Kenyon G.L.; Cohen F.E.; Chen X.; Gong B.; Dominguez J.N.; Davidson E.; Kurzban G.; Miller R.E.; Nuzum E.O.; Rosenthal P.J.; McKerrow J.H.; \nIn vitro antimalarial activity of chalcones and their derivatives. J Med Chem  1995,38(26),5031-5037","journal-title":"J Med Chem"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1021\/jm058208o","volume":"48","author":"Dom\u00ednguez J.N.","year":"2005","unstructured":"Dom\u00ednguez J.N.; Le\u00f3n C.; Rodrigues J.; Gamboa de Dom\u00ednguez N.; Gut J.; Rosenthal P.J.; Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives. J Med Chem  2005,48(10),3654-3658","journal-title":"J Med Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1128\/AAC.38.7.1470","volume":"38","author":"Chen M.","year":"1994","unstructured":"Chen M.; Theander T.G.; Christensen S.B.; Hviid L.; Zhai L.; Kharazmi A.; Licochalcone A.; Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob Agents Chemother  1994,38(7),1470-1475","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1086\/514129","volume":"176","author":"Chen M.","year":"1997","unstructured":"Chen M.; Christensen S.B.\u00d8.; Zhai L.; Rasmussen M.H.; Theander T.G.; Fr\u00d8kjaer S.; Steffansen B.; Davidsen J.; Kharazmi A.; The novel oxygenated chalcone, 2,4-dimethoxy-4\u2032-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo. J Infect Dis  1997,176(5),1327-1333","journal-title":"J Infect Dis"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1039\/c1md00129a","volume":"2","author":"Shah F.","year":"2011","unstructured":"Shah F.; Wu Y.; Gut J.; Pedduri Y.; Legac J.; Rosenthal P.J.; Avery M.A.; Design, synthesis and biological evaluation of novel benzothiazole and triazole analogs as falcipain inhibitors. MedChemComm  2011,2(12),1201-1207","journal-title":"MedChemComm"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"39410","DOI":"10.1039\/C9RA06571G","volume":"9","author":"Singh A.","year":"2019","unstructured":"Singh A.; Kalamuddin M.; Mohmmed A.; Malhotra P.; Hoda N.; Quinoline-triazole hybrids inhibit falcipain-2 and arrest the development of Plasmodium falciparum at the trophozoite stage. RSC Advances  2019,9(67),39410-39421","journal-title":"RSC Advances"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1016\/j.bmc.2016.06.003","volume":"24","author":"Schmidt I.","year":"2016","unstructured":"Schmidt I.; Pradel G.; Sologub L.; Golzmann A.; Ngwa C.J.; Kucharski A.; Schirmeister T.; Holzgrabe U.; Bistacrine derivatives as new potent antimalarials. Bioorg Med Chem  2016,24(16),3636-3642","journal-title":"Bioorg Med Chem"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1016\/j.bmc.2017.06.051","volume":"25","author":"Schmidt I.","year":"2017","unstructured":"Schmidt I.; G\u00f6llner S.; Fu\u00df A.; Stich A.; Kucharski A.; Schirmeister T.; Katzowitsch E.; Bruhn H.; Miliu A.; Krauth-Siegel R.L.; Holzgrabe U.; Bistacrines as potential antitrypanosomal agents. Bioorg Med Chem  2017,25(16),4526-4531","journal-title":"Bioorg Med Chem"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bmcl.2011.12.011","volume":"22","author":"Huang H.","year":"2012","unstructured":"Huang H.; Lu W.; Li X.; Cong X.; Ma H.; Liu X.; Zhang Y.; Che P.; Ma R.; Li H.; Shen X.; Jiang H.; Huang J.; Zhu J.; Design and synthesis of small molecular dual inhibitor of falcipain-2 and dihydrofolate reductase as antimalarial agent. Bioorg Med Chem Lett  2012,22(2),958-962","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.1016\/j.bmc.2017.10.017","volume":"25","author":"Chen W.","year":"2017","unstructured":"Chen W.; Huang Z.; Wang W.; Mao F.; Guan L.; Tang Y.; Jiang H.; Li J.; Huang J.; Jiang L.; Zhu J.; Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely. Bioorg Med Chem  2017,25(24),6467-6478","journal-title":"Bioorg Med Chem"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.sbi.2020.02.004","volume":"62","author":"Bhat A.S.","year":"2020","unstructured":"Bhat A.S.; Dustin Schaeffer R.; Kinch L.; Medvedev K.E.; Grishin N.V.; Recent advances suggest increased influence of selective pressure in allostery. Curr Opin Struct Biol  2020,62,183-188","journal-title":"Curr Opin Struct Biol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1021\/acs.chemrev.5b00631","volume":"116","author":"Wagner J.R.","year":"2016","unstructured":"Wagner J.R.; Lee C.T.; Durrant J.D.; Malmstrom R.D.; Feher V.A.; Amaro R.E.; Emerging computational methods for the rational discovery of allosteric drugs. Chem Rev  2016,116(11),6370-6390","journal-title":"Chem Rev"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1038\/ncomms4287","volume":"5","author":"Novinec M.","year":"2014","unstructured":"Novinec M.; Koren\u010d M.; Caflisch A.; Ranganathan R.; Lenar\u010di\u010d B.; Baici A.; A novel allosteric mechanism in the cysteine peptidase cathepsin K discovered by computational methods. Nat Commun  2014,5(1),3287","journal-title":"Nat Commun"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"e106642","DOI":"10.1371\/journal.pone.0106642","volume":"9","author":"Novinec M.","year":"2014","unstructured":"Novinec M.; Lenar\u010di\u010d B.; Baici A.; Probing the activity modification space of the cysteine peptidase cathepsin K with novel allosteric modifiers. PLoS One  2014,9(9),e106642","journal-title":"PLoS One"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1002\/1873-3468.12495","volume":"590","author":"Novinec M.","year":"2016","unstructured":"Novinec M.; Rebernik M.; Lenar\u010di\u010d B.; An allosteric site enables fine-tuning of cathepsin K by diverse effectors. FEBS Lett  2016,590(24),4507-4518","journal-title":"FEBS Lett"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1016\/j.bmc.2013.04.047","volume":"21","author":"Marques A.F.","year":"2013","unstructured":"Marques A.F.; Esser D.; Rosenthal P.J.; Kassack M.U.; Lima L.M.T.R.; Falcipain-2 inhibition by suramin and suramin analogues. Bioorg Med Chem  2013,21(13),3667-3673","journal-title":"Bioorg Med Chem"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.abb.2015.03.007","volume":"573","author":"Marques A.F.","year":"2015","unstructured":"Marques A.F.; Gomes P.S.F.C.; Oliveira P.L.; Rosenthal P.J.; Pascutti P.G.; Lima L.M.T.R.; Allosteric regulation of the Plasmodium falciparum cysteine protease falcipain-2 by heme. Arch Biochem Biophys  2015,573,92-99","journal-title":"Arch Biochem Biophys"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1016\/j.csbj.2021.10.011","volume":"19","author":"Okeke C.J.","year":"2021","unstructured":"Okeke C.J.; Musyoka T.M.; Sheik Amamuddy O.; Barozi V.; Tastan Bishop \u00d6.; Allosteric pockets and dynamic residue network hubs of falcipain 2 in mutations including those linked to artemisinin resistance. Comput Struct Biotechnol J  2021,19,5647-5666","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.1021\/acs.jpcb.9b05021","volume":"123","author":"Hern\u00e1ndez Gonz\u00e1lez J.E.","year":"2019","unstructured":"Hern\u00e1ndez Gonz\u00e1lez J.E.; Hern\u00e1ndez Alvarez L.; Pascutti P.G.; Leite V.B.P.; Prediction of noncompetitive inhibitor binding mode reveals promising site for allosteric modulation of falcipain-2. J Phys Chem B  2019,123(34),7327-7342","journal-title":"J Phys Chem B"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s10822-021-00420-7","volume":"35","author":"Hern\u00e1ndez Gonz\u00e1lez J.E.","year":"2021","unstructured":"Hern\u00e1ndez Gonz\u00e1lez J.E.; Salas-Sarduy E.; Hern\u00e1ndez Alvarez L.; Barreto Gomes D.E.; Pascutti P.G.; Oostenbrink C.; Leite V.B.P.; \nIn silico identification of noncompetitive inhibitors targeting an uncharacterized allosteric site of falcipain-2. J Comput Aided Mol Des  2021,35(10),1067-1079","journal-title":"J Comput Aided Mol Des"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3389\/fchem.2019.00534","volume":"7","author":"Alberca L.N.","year":"2019","unstructured":"Alberca L.N.; Chuguransky S.R.; \u00c1lvarez C.L.; Talevi A.; Salas-Sarduy E.; \nIn silico guided drug repurposing: Discovery of new competitive and non-competitive inhibitors of falcipain-2. Front Chem  2019,7,534","journal-title":"Front Chem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1021\/acs.jcim.1c01189","volume":"62","author":"Hern\u00e1ndez Gonz\u00e1lez J.E.","year":"2022","unstructured":"Hern\u00e1ndez Gonz\u00e1lez J.E.; Alberca L.N.; Masforrol Gonz\u00e1lez Y.; Reyes Acosta O.; Talevi A.; Salas-Sarduy E.; Tetracycline derivatives inhibit plasmodial cysteine protease falcipain-2 through binding to a distal allosteric site. J Chem Inf Model  2022,62(1),159-175","journal-title":"J Chem Inf Model"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"16193","DOI":"10.1038\/s41598-018-34564-8","volume":"8","author":"Pant A.","year":"2018","unstructured":"Pant A.; Kumar R.; Wani N.A.; Verma S.; Sharma R.; Pande V.; Saxena A.K.; Dixit R.; Rai R.; Pandey K.C.; Allosteric site inhibitor disrupting auto-processing of malarial cysteine proteases. Sci Rep  2018,8(1),16193","journal-title":"Sci Rep"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1016\/j.bpj.2010.02.034","volume":"98","author":"Stjernschantz E.","year":"2010","unstructured":"Stjernschantz E.; Oostenbrink C.; Improved ligand-protein binding affinity predictions using multiple binding modes. Biophys J  2010,98(11),2682-2691","journal-title":"Biophys J"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1021\/ci100354x","volume":"51","author":"Lindstr\u00f6m A.","year":"2011","unstructured":"Lindstr\u00f6m A.; Edvinsson L.; Johansson A.; Andersson C.D.; Andersson I.E.; Raubacher F.; Linusson A.; Postprocessing of docked protein-ligand complexes using implicit solvation models. J Chem Inf Model  2011,51(2),267-282","journal-title":"J Chem Inf Model"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1021\/acs.jctc.6b00201","volume":"12","author":"Clark A.J.","year":"2016","unstructured":"Clark A.J.; Tiwary P.; Borrelli K.; Feng S.; Miller E.B.; Abel R.; Friesner R.A.; Berne B.J.; Prediction of protein\u2013ligand binding poses via a combination of induced fit docking and metadynamics simulations. J Chem Theory Comput  2016,12(6),2990-2998","journal-title":"J Chem Theory Comput"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1021\/jm0493717","volume":"47","author":"Desai P.V.","year":"2004","unstructured":"Desai P.V.; Patny A.; Sabnis Y.; Tekwani B.; Gut J.; Rosenthal P.; Srivastava A.; Avery M.; Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database. J Med Chem  2004,47(26),6609-6615","journal-title":"J Med Chem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ejmech.2014.11.061","volume":"90","author":"Sharma R.K.","year":"2015","unstructured":"Sharma R.K.; Younis Y.; Mugumbate G.; Njoroge M.; Gut J.; Rosenthal P.J.; Chibale K.; Synthesis and structure\u2013activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2. Eur J Med Chem  2015,90,507-518","journal-title":"Eur J Med Chem"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1021\/jm0505765","volume":"49","author":"Desai P.V.","year":"2006","unstructured":"Desai P.V.; Patny A.; Gut J.; Rosenthal P.J.; Tekwani B.; Srivastava A.; Avery M.; Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory. J Med Chem  2006,49(5),1576-1584","journal-title":"J Med Chem"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"850176","DOI":"10.3389\/fphar.2022.850176","volume":"13","author":"Uddin A.","year":"2022","unstructured":"Uddin A.; Gupta S.; Mohammad T.; Shahi D.; Hussain A.; Alajmi M.F.; El-Seedi H.R.; Hassan I.; Singh S.; Abid M.; Target-based virtual screening of natural compounds identifies a potent antimalarial with selective falcipain-2 inhibitory activity. Front Pharmacol  2022,13,850176","journal-title":"Front Pharmacol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"Friesner R.A.","year":"2004","unstructured":"Friesner R.A.; Banks J.L.; Murphy R.B.; Halgren T.A.; Klicic J.J.; Mainz D.T.; Repasky M.P.; Knoll E.H.; Shelley M.; Perry J.K.; Shaw D.E.; Francis P.; Shenkin P.S.; Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem  2004,47(7),1739-1749","journal-title":"J Med Chem"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1016\/j.bmcl.2004.06.091","volume":"14","author":"Li H.","year":"2004","unstructured":"Li H.; Li C.; Gui C.; Luo X.; Chen K.; Shen J.; Wang X.; Jiang H.; GAsDock: A new approach for rapid flexible docking based on an improved multi-population genetic algorithm. Bioorganic Med Chem  2004,14(18),4671-4676","journal-title":"Bioorganic Med Chem"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1016\/j.bmc.2012.04.063","volume":"20","author":"Wang L.","year":"2012","unstructured":"Wang L.; Li X.; Zhang S.; Lu W.; Liao S.; Liu X.; Shan L.; Shen X.; Jiang H.; Zhang W.; Huang J.; Li H.; Natural products as a gold mine for selective matrix metalloproteinases inhibitors. Bioorg Med Chem  2012,20(13),4164-4171","journal-title":"Bioorg Med Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1359-6446(97)01079-9","volume":"2","author":"Kubinyi H.","year":"1997","unstructured":"Kubinyi H.; QSAR and 3D QSAR in drug design Part 1: methodology. Drug Discov Today  1997,2(11),457-467","journal-title":"Drug Discov Today"},{"key":"ref=147","first-page":"161","volume":"1","author":"G\u00e1lvez J.","year":"2015","unstructured":"G\u00e1lvez J.; G\u00e1lvez-Llompart M.; Garc\u00eda-Domenech R.;  Advances in Mathematical Chemistry and Applications  2015,1,161-195","journal-title":"Advances in Mathematical Chemistry and Applications"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00894-011-1177-2","volume":"18","author":"Chintakrindi A.S.","year":"2012","unstructured":"Chintakrindi A.S.; Shaikh M.S.; Coutinho E.C.; De novo design of 7-aminocoumarin derivatives as novel falcipain-3 inhibitors. J Mol Model  2012,18(4),1481-1493","journal-title":"J Mol Model"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1016\/j.bmcl.2011.09.107","volume":"21","author":"Potshangbam A.M.","year":"2011","unstructured":"Potshangbam A.M.; Tanneeru K.; Reddy B.M.; Guruprasad L.; 3D-QSAR and molecular docking studies of 2-pyrimidinecarbonitrile derivatives as inhibitors against falcipain-3. Bioorg Med Chem Lett  2011,21(23),7219-7223","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10822-011-9459-4","volume":"25","author":"Teixeira C.","year":"2011","unstructured":"Teixeira C.; Gomes J.R.B.; Couesnon T.; Gomes P.; Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium falciparum cysteine proteases inhibitors. J Comput Aided Mol Des  2011,25(8),763-775","journal-title":"J Comput Aided Mol Des"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2174\/0929867311320150008","volume":"20","author":"Wang J.","year":"2013","unstructured":"Wang J.; Li Y.; Yang Y.; Zhang S.; Yang L.; Profiling the structural determinants of heteroarylnitrile scaffold-based derivatives as falcipain-2 inhibitors by in silico methods. Curr Med Chem  2013,20(15),2032-2042","journal-title":"Curr Med Chem"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1039\/c3mb70105k","volume":"9","author":"Wang J.","year":"2013","unstructured":"Wang J.; Li F.; Li Y.; Yang Y.; Zhang S.; Yang L.; Structural features of falcipain-3 inhibitors: An in silico study. Mol Biosyst  2013,9(9),2296-2310","journal-title":"Mol Biosyst"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jtbi.2016.05.019","volume":"403","author":"Thillainayagam M.","year":"2016","unstructured":"Thillainayagam M.; Anbarasu A.; Ramaiah S.; Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in Plasmodium falciparum. J Theor Biol  2016,403,110-128","journal-title":"J Theor Biol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"Wolber G.","year":"2005","unstructured":"Wolber G.; Langer T.; LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model  2005,45(1),160-169","journal-title":"J Chem Inf Model"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/9781119161110.ch20","volume":"281","author":"Seidel T.","year":"2017","unstructured":"Seidel T.; Bryant S.D.; Ibis G.; Poli G.; Langer T.; 3D pharmacophore modeling techniques in computer-aided molecular design using LigandScout. J Tutorials Chemoinform  2017,281,279-309","journal-title":"J Tutorials Chemoinform"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/14756366.2018.1564288","volume":"34","author":"Allangba K.N.G.P.G.","year":"2019","unstructured":"Allangba K.N.G.P.G.; Keita M.; Kre N\u2019Guessan R.; Megnassan E.; Frecer V.; Miertus S.; Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone\u2013chalcone and isatin\u2013chalcone inhibitors probing the S2 active site pocket. J Enzyme Inhib Med Chem  2019,34(1),547-561","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1021\/jp015514e","volume":"106","author":"Southall N.T.","year":"2002","unstructured":"Southall N.T.; Dill K.A.; Haymet A.D.J.; A view of the hydrophobic effect. J Phys Chem B  2002,106(3),521-533","journal-title":"J Phys Chem B"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"17889","DOI":"10.1073\/pnas.1114107108","volume":"108","author":"Snyder P.W.","year":"2011","unstructured":"Snyder P.W.; Mecinovi\u0107 J.; Moustakas D.T.; Thomas S.W.; Harder M.; Mack E.T.; Lockett M.R.; H\u00e9roux A.; Sherman W.; Whitesides G.M.; Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase. Proc Natl Acad Sci USA  2011,108(44),17889-17894","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1021\/ci3005786","volume":"53","author":"Garc\u00eda-Sosa A.T.","year":"2013","unstructured":"Garc\u00eda-Sosa A.T.; Hydration properties of ligands and drugs in protein binding sites: Tightly-bound, bridging water molecules and their effects and consequences on molecular design strategies. J Chem Inf Model  2013,53(6),1388-1405","journal-title":"J Chem Inf Model"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1073\/pnas.0610202104","volume":"104","author":"Young T.","year":"2007","unstructured":"Young T.; Abel R.; Kim B.; Berne B.J.; Friesner R.A.; Motifs for molecular recognition exploiting hydrophobic enclosure in protein\u2013ligand binding. Proc Natl Acad Sci USA  2007,104(3),808-813","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1021\/ja0771033","volume":"130","author":"Abel R.","year":"2008","unstructured":"Abel R.; Young T.; Farid R.; Berne B.J.; Friesner R.A.; Role of the active-site solvent in the thermodynamics of factor Xa ligand binding. J Am Chem Soc  2008,130(9),2817-2831","journal-title":"J Am Chem Soc"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1021\/ci2005516","volume":"52","author":"Shah F.","year":"2012","unstructured":"Shah F.; Gut J.; Legac J.; Shivakumar D.; Sherman W.; Rosenthal P.J.; Avery M.A.; Computer-aided drug design of falcipain inhibitors: Virtual screening, structure-activity relationships, hydration site thermodynamics, and reactivity analysis. J Chem Inf Model  2012,52(3),696-710","journal-title":"J Chem Inf Model"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/minf.201100135","volume":"31","author":"Homeyer N.","year":"2012","unstructured":"Homeyer N.; Gohlke H.; Free energy calculations by the molecular mechanics poisson\u2212boltzmann surface area method. Mol Inform  2012,31(2),114-122","journal-title":"Mol Inform"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"5499","DOI":"10.1021\/acs.jcim.0c00294","volume":"60","author":"Hern\u00e1ndez Gonz\u00e1lez J.E.","year":"2020","unstructured":"Hern\u00e1ndez Gonz\u00e1lez J.E.; Hern\u00e1ndez Alvarez L.; Leite V.B.P.; Pascutti P.G.; Water bridges play a key role in affinity and selectivity for malarial protease falcipain-2. J Chem Inf Model  2020,60(11),5499-5512","journal-title":"J Chem Inf Model"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.ejmech.2012.05.022","volume":"54","author":"P\u00e9rez B.C.","year":"2012","unstructured":"P\u00e9rez B.C.; Teixeira C.; Figueiras M.; Gut J.; Rosenthal P.J.; Gomes J.R.B.; Gomes P.; Novel cinnamic acid\/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: Towards the development of potential dual action antimalarials. Eur J Med Chem  2012,54,887-899","journal-title":"Eur J Med Chem"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"Jumper J.","year":"2021","unstructured":"Jumper J.; Evans R.; Pritzel A.; Green T.; Figurnov M.; Ronneberger O.; Tunyasuvunakool K.; Bates R.; \u017d\u00eddek A.; Potapenko A.; Bridgland A.; Meyer C.; Kohl S.A.A.; Ballard A.J.; Cowie A.; Romera-Paredes B.; Nikolov S.; Jain R.; Adler J.; Back T.; Petersen S.; Reiman D.; Clancy E.; Zielinski M.; Steinegger M.; Pacholska M.; Berghammer T.; Bodenstein S.; Silver D.; Vinyals O.; Senior A.W.; Kavukcuoglu K.; Kohli P.; Hassabis D.; Highly accurate protein structure prediction with AlphaFold. Nature  2021,596(7873),583-589","journal-title":"Nature"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41596-021-00659-2","volume":"17","author":"Gentile F.","year":"2022","unstructured":"Gentile F.; Yaacoub J.C.; Gleave J.; Fernandez M.; Ton A.T.; Ban F.; Stern A.; Cherkasov A.; Artificial intelligence\u2013enabled virtual screening of ultra-large chemical libraries with deep docking. Nat Protoc  2022,17(3),672-697","journal-title":"Nat Protoc"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10822-013-9685-z","volume":"27","author":"Mugumbate G.","year":"2013","unstructured":"Mugumbate G.; Newton A.S.; Rosenthal P.J.; Gut J.; Moreira R.; Chibale K.; Guedes R.C.; Novel anti-Plasmodial hits identified by virtual screening of the ZINC database. J Comput Aided Mol Des  2013,27(10),859-871","journal-title":"J Comput Aided Mol Des"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"829043","DOI":"10.3389\/fddsv.2022.829043","volume":"2","author":"Bajorath J.","year":"2022","unstructured":"Bajorath J.; Deep machine learning for computer-aided drug design. Front Drug Discov  2022,2,829043","journal-title":"Front Drug Discov"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fchem.2018.00315","volume":"6","author":"Kumar A.","year":"2018","unstructured":"Kumar A.; Zhang K.Y.J.; Advances in the development of shape similarity methods and their application in drug discovery. Front Chem  2018,6,315","journal-title":"Front Chem"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41563-019-0332-5","volume":"18","author":"Bhhatarai B.","year":"2019","unstructured":"Bhhatarai B.; Walters W.P.; Hop C.E.C.A.; Lanza G.; Ekins S.; Opportunities and challenges using artificial intelligence in ADME\/Tox. Nat Mater  2019,18(5),418-422","journal-title":"Nat Mater"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230913165219","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/221039\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230913165219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T10:01:36Z","timestamp":1713952896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/221039\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":171,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230913165219","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}